Previous investigations suggested AFP may be a marker of tumor aggressiveness.12,13 Experimental studies confirmed inhibition of AFP mRNA expression could inhibit the proliferative activity in HCC cell line.14,15 Recently, Canly et al.16 suggested AFP-specific immunotherapy could also inhibit the growth of autochthonous hepatocellular carcinoma in mice. The gene discussed is AFP; the disease is neoplasm.